Financials in USD. Standardized financial statements.
A compact view of how Biotest AG turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $726.20M | $684.60M | $516.10M | $515.60M | $484.20M | $419.10M | $400.30M | $378.10M | $553.10M | $589.60M |
| Revenue Growth? | +6.1% | +32.6% | +0.1% | +6.5% | +15.5% | +4.7% | +5.9% | -31.6% | -6.2% | 0.0% |
| Cost of Revenue? | $502.40M | $404.30M | $391.20M | $434.90M | $354.10M | $290.30M | $265.50M | $254.60M | $349.60M | $325.70M |
| Gross Profit? | $223.80M | $280.30M | $124.90M | $80.70M | $130.10M | $128.80M | $134.80M | $123.50M | $203.50M | $208.90M |
| Gross Margin? | +30.8% | +40.9% | +24.2% | +15.7% | +26.9% | +30.7% | +33.7% | +32.7% | +36.8% | +35.4% |
| Operating Expenses? | $129.30M | $136.80M | $133.40M | $132.80M | $132.60M | $135.50M | $132.30M | $156.80M | $134.20M | $212.80M |
| Operating Income? | $94.50M | $143.50M | -$16.60M | -$47.10M | -$1.30M | -$1.20M | $10.60M | -$9.30M | $35.20M | $37.30M |
| EBITDA? | $120.40M | $182.20M | $24.70M | -$18.30M | $13.90M | $41.10M | $29.60M | $5.20M | $56.60M | $65.40M |
| Income Before Tax | $46.50M | $106.30M | -$30.80M | -$62.60M | -$30.00M | -$1.30M | -$6.00M | -$26.00M | $24.00M | $34.80M |
| Income Tax Expense | $20.20M | -$20.70M | $800,000 | $700,000 | $1.40M | $3.40M | $6.90M | -$9.60M | $18.20M | $7.80M |
| Net Income? | $26.40M | $127.00M | -$31.70M | -$63.40M | -$31.40M | -$4.70M | $181.30M | -$3.50M | -$45.80M | -$82.50M |
| EPS? | $0.71 | $3.21 | $-0.80 | $-1.61 | $-0.79 | $-0.12 | $4.58 | $-0.09 | $-1.16 | $-2.08 |
| Diluted EPS? | $0.71 | $3.21 | $-0.80 | $-1.60 | $-0.79 | $-0.12 | $4.58 | $-0.09 | $-1.16 | $-2.08 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality